EDIT vs SHW · rev $32.3M vs P/E 29, rev $23.10B
Editas Medicine Inc (EDIT) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported SHW revenue for 2024-12-31 was $23.10B. Net income was $2.68B. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
EDIT currently screens at market cap $375.2M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the EDIT and SHW stock pages for the full models.
Not investment advice.